Traditional recovery programs have long been pivotal in the battle against substance use disorders. However, their effectiveness in preventing relapse has been questioned. Studies show that the ...

ABBV's neuroscience sales jump 26% in Q1, driven by Vraylar, migraine drugs and Botox as new therapies fuel growth.

Neuroscience is a vast field of study containing a range of narrower subfields. Each involves a spotlight on the brain and other parts of the nervous system, connecting them to one or more zones of ...